IRCT138806211241N2已完成2 期
Anti Micro Albuminuric Effect of Spironolatone with or without Losartan in Diabetic type II Patients
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 35 years 至 75 years（—）
- 性别
- All
入选标准
- •This study will done in 35-75 years old diabetic patient with microalbuminuria. Exclusion criteria: 1)systolic blood pressure > 180mmHg; 2)Diastolic blood pressure > 110mmHg; 3)Serum k > 5.5 mg/dl; 4)CVA or MI in 6 month ago; 5)Treatment whit corticosteroids, NSAIDs, immunosuppressive; 6)Patients whit renovascular disease, obstructive uropathy, collagenous disease, Malignancy, alcohol users, addiction; 7)Pregnant or breast fed women; 8)HbA1C > 8%.
排除标准
- 未提供
研究者
相似试验
已完成
4 期
Impacts of spironolactone on albuminuria in patients with diabetic nephropathy and hypertensioDiabetic nephropathyJPRN-UMIN000008016Department of Nephrology, Nagoya University Graduate School of Medicine50
已完成
不适用
anti-albuminuric effect of 1ow-dose spironolactone in patients with diabetic nephropathydiabetic nephropathyJPRN-UMIN000022999Diabetes, Endocrinology and Metabolism, Shinshu University Hospital130
已完成
3 期
The Efficacy of Spironolactone in Continuous Ambulatory Peritoneal Dialysis Patients with Hypokalemia: A Randomized Controlled TrialA randomized controlled trial was conducted in CAPD patients with serum potassium <3.5 mEq/L.End stage renal disease,Hypokalemia,Peritoneal dialysis,SpironolactoneTCTR20200818005one50
已完成
2 期
The Effect of Spironolactone in Treatment of Essential HypertensioHypertension.Essential (primary) hypertensionIRCT201502011525N6Shiraz University of Midical Sciences40
尚未招募
4 期
Comparing Medications for Reducing Kidney Damage in Diabetes: A Study on Dapagliflozin Alone and with EplerenoneCTRI/2024/01/061952Dr Nikhil Kumar